Tatva Chintan Pharma Chem (NSE:TATVA) Total Equity: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:TATVA Tatva Chintan Pharma Chem Ltd NSE:TATVA
82 GF Score
Price ₹1,722.40
GF Value ₹1,493.31
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Tatva Chintan Pharma Chem Total Equity?

Tatva Chintan Pharma Chem NSE:TATVA +1.27% 82 Total Equity is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:TATVA with a GF Score™ of 82/100 and a GF Value™ of ₹1,493.31 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Tatva Chintan Pharma Chem's total equity for the quarter that ended in Jun. 2026 was ₹0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Tatva Chintan Pharma Chem Total Equity Historical Data

* Premium members only.

The historical data trend for Tatva Chintan Pharma Chem's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tatva Chintan Pharma Chem Total Equity Chart

Tatva Chintan Pharma Chem Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial 4,730.89 5,147.91 7,370.82 7,388.24 7,817.59

Tatva Chintan Pharma Chem Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 7,543.89 0.00 7,817.59 0.00
NSE:TATVA
82GF Score
Tatva Chintan Pharma Chem Ltd NSE:TATVA
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tatva Chintan Pharma Chem Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Tatva Chintan Pharma Chem's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=10036.94-2219.35
=7,818

Tatva Chintan Pharma Chem's Total Equity for the quarter that ended in Jun. 2026 is calculated as

Total Equity=Total Assets(Q: Jun. 2026 )-Total Liabilities(Q: Jun. 2026 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹0 Mil mean?
Tatva Chintan Pharma Chem (NSE:TATVA) has a Total Equity of ₹0 Mil as of Jun. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Tatva Chintan Pharma Chem and its competitors.
Is Tatva Chintan Pharma Chem's Total Equity too high?
Tatva Chintan Pharma Chem's current Total Equity is ₹0 Mil. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's Total Equity compare to LIN and SHW?
Tatva Chintan Pharma Chem's Total Equity of ₹0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Chemicals company?
A good Total Equity depends on the Chemicals industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Tatva Chintan Pharma Chem and its competitors. Tatva Chintan Pharma Chem's current Total Equity is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (NSE:TATVA) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,493.31, compared to a current price of ₹1,722.40 — trading 15.3% above its estimated fair value. The current Total Equity is ₹0 Mil. Tatva Chintan Pharma Chem's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (NSE:TATVA), the current Total Equity is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tatva Chintan Pharma Chem (NSE:TATVA) Overvalued in 2026?

Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be overvalued. The current stock price of ₹1,722.40 is trading 15.3% above its estimated GF Value™ of ₹1,493.31. GuruFocus considers Tatva Chintan Pharma Chem to be Modestly Overvalued.

Key valuation signals for NSE:TATVA:

  • Total Equity: ₹0 Mil
  • GF Value™: ₹1,493.31 vs. price of ₹1,722.40 (15.3% above fair value)
  • GF Score™: 82/100 with 7 warning signs

No single metric tells the full story. See the NSE:TATVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tatva Chintan Pharma Chem Business Description

Other Exchanges 543321:India
Address Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
82GF Score

Get the complete analysis for NSE:TATVA

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,722.40
Price
₹1,493.31
GF Value